According to the pact, Akrimax Pharma got license from NovaDel Pharma for the manufacturing and commercialization of NitroMist in North America.
NovaDel Pharma’s NitroMist (nitroglycerin sublingual spray) belongs to a group of drugs called nitrates, which is used to treat or prevent attacks of chest pain (angina).
NovaDel Pharma is a specialty pharmaceutical company that develops oral spray formulations for a range of marketed pharmaceutical products.